Bronchoalveolar lavage in idiopathic pulmonary fibrosis: what does it tell us?
- PMID: 20471812
- DOI: 10.1016/j.rmed.2010.03.019
Bronchoalveolar lavage in idiopathic pulmonary fibrosis: what does it tell us?
Abstract
Bronchoalveolar lavage (BAL) has only a limited role in diagnosis of idiopathic pulmonary fibrosis (IPF). A finding of raised neutrophils (>5%) and eosinophils (>2%) is characteristic but not diagnostic of IPF. BAL cell count does not clearly differentiate between fibrotic non-specific interstitial pneumonia and IPF either diagnostically or prognostically. BAL in IPF should be considered in all patients with suspected infection, malignancy or acute exacerbations. In such cases, it may be diagnostic. Because of few and conflicting results BAL fluid analysis has very little clinical relevance determining prognosis and response to treatment in IPF.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Bronchoalveolar lavage in sarcoidosis.Semin Respir Crit Care Med. 2007 Oct;28(5):486-95. doi: 10.1055/s-2007-991521. Semin Respir Crit Care Med. 2007. PMID: 17975776 Review.
-
S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.Respir Med. 2012 Apr;106(4):571-80. doi: 10.1016/j.rmed.2011.12.010. Epub 2011 Dec 30. Respir Med. 2012. PMID: 22209187
-
Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 2009 Jun 1;179(11):1043-7. doi: 10.1164/rccm.200808-1313OC. Epub 2009 Feb 26. Am J Respir Crit Care Med. 2009. PMID: 19246718
-
[Diagnostic value of secretory products of eosinophils and neutrophils in bronchoalveolar lavage in patients with idiopathic lung fibrosis].Wien Klin Wochenschr. 1993;105(14):387-92. Wien Klin Wochenschr. 1993. PMID: 8396288 German.
-
Bronchoalveolar lavage in idiopathic interstitial lung diseases.Semin Respir Crit Care Med. 2007 Oct;28(5):496-503. doi: 10.1055/s-2007-991522. Semin Respir Crit Care Med. 2007. PMID: 17975777 Review.
Cited by
-
The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.J Negat Results Biomed. 2017 Mar 1;16(1):4. doi: 10.1186/s12952-017-0069-0. J Negat Results Biomed. 2017. PMID: 28245857 Free PMC article.
-
Inhalable powder formulation of pirfenidone with reduced phototoxic risk for treatment of pulmonary fibrosis.Pharm Res. 2013 Jun;30(6):1586-96. doi: 10.1007/s11095-013-0997-4. Epub 2013 Feb 21. Pharm Res. 2013. PMID: 23430486
-
Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples.Breathe (Sheff). 2020 Sep;16(3):200067. doi: 10.1183/20734735.0067-2020. Breathe (Sheff). 2020. PMID: 33447271 Free PMC article.
-
The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.PLoS One. 2022 Jan 6;17(1):e0262082. doi: 10.1371/journal.pone.0262082. eCollection 2022. PLoS One. 2022. PMID: 34990493 Free PMC article.
-
Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.Pharm Res. 2016 Jun;33(6):1447-55. doi: 10.1007/s11095-016-1887-3. Epub 2016 Mar 14. Pharm Res. 2016. PMID: 26975360
MeSH terms
LinkOut - more resources
Full Text Sources